Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)

NCT04909424 is registered in ClinicalTrials.gov with Clinique Pasteur as lead sponsor.

NCT NCT04909424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04909424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)
Lead sponsor
Clinique Pasteur
Phase
Observational
Overall status
Completed
Start date
June 17, 2021
Completion date
November 23, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease